£595.00

It has never been this cheap. We have no record of a lower price.

£595 today · cheaper than every other day in the last 3 months

Bladder Cancer Therapeutics Outlook Japan 2016-2021

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 18 days · 18 data points (no recent data)

Historical
Generating forecast…
£595.00 £565.25 £577.15 £589.05 £600.95 £612.85 £624.75 11 August 2026 15 August 2026 19 August 2026 23 August 2026 28 August 2026
View at Amazon ↗

Price data last checked 73 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 18 days • 1 price levels

Days at Price
18 days 0 5 9 14 18 £595 Days at Price

Price Analysis

Most common price: £595 (18 days, 100.0%)

Price range: £595 - £595

Price levels: 1 different prices over 18 days

Description

Gain specialized insights with The 2016-2021 Outlook for Bladder Cancer Therapeutics in Japan. This professional resource provides a focused look at the pharmaceutical landscape and therapeutic trends within the Japanese market. Published by ICON Group International, Inc., this book serves as a targeted study for those analyzing economic trends and medical market developments. It is an essential addition for professionals studying business, finance, and economics through the lens of healthcare market data.

Key Features

Provides a specialized outlook for bladder cancer therapeutics in Japan from 2016 to 2021.

Authored and published by ICON Group International, Inc. for professional use.

Focuses on the intersection of business, finance, and economic analysis within the medical sector.

Serves as a detailed resource for studying econometrics and market trends in Japan.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
22 September 2015
Listed Since
16 November 2016

Similar Products You Might Like

World Outlook for Bladder Cancer Therapeutics 2025-2030
98% match

World Outlook for Bladder Cancer Therapeutics 2025-2030

Price unavailable
World Outlook: Transitional Cell Bladder Cancer Therapeutics
97% match

World Outlook: Transitional Cell Bladder Cancer Therapeutics

Price unavailable
Overactive Bladder Treatments in India 2023-2028 Outlook
97% match

Overactive Bladder Treatments in India 2023-2028 Outlook

£515.00 25 Aug 2026
Uterine Cancer Therapeutics and Diagnostics in India Outlook
97% match

Uterine Cancer Therapeutics and Diagnostics in India Outlook

£515.00 05 Nov 2026
Prostate Cancer Therapeutics Outlook in Japan (2016-2021)
97% match

Prostate Cancer Therapeutics Outlook in Japan (2016-2021)

£595.00 23 Sep 2026
Uterine Cancer Therapeutics and Diagnostics Outlook 2023-2028
97% match

Uterine Cancer Therapeutics and Diagnostics Outlook 2023-2028

£520.00 06 Nov 2026
US Overactive Bladder Treatment Outlook 2023-2028 Study
97% match

US Overactive Bladder Treatment Outlook 2023-2028 Study

£520.00 28 Aug 2026
US Cancer Supportive Care Outlook 2023-2028 Study Report
97% match

US Cancer Supportive Care Outlook 2023-2028 Study Report

£520.00 07 Nov 2026
Bladder Cancer Breakthroughs: A Global Perspective on Diagnosis, Treatment, and Patient Care
97% match

Bladder Cancer Breakthroughs: A Global Perspective on Diagnosis, Treatment, and Patient Care

Elsevier

£119.36 24 Sep 2026
The 2016-2021 Outlook for Urological Catheters in the United States
97% match

The 2016-2021 Outlook for Urological Catheters in the United States

£595.00 28 Aug 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India

£515.00 30 Sep 2026
The 2026-2031 World Outlook for Overactive Bladder Therapeutics
97% match

The 2026-2031 World Outlook for Overactive Bladder Therapeutics

£885.00 19 Sep 2026
India Cancer Supportive Care Drugs Outlook 2023-2028
97% match

India Cancer Supportive Care Drugs Outlook 2023-2028

£515.00 06 Nov 2026
Cancer Supportive Care Drugs Outlook 2023-2028 Report
97% match

Cancer Supportive Care Drugs Outlook 2023-2028 Report

£520.00 06 Nov 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£520.00 30 Sep 2026
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics
97% match

The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£790.00 01 Oct 2026
The 2021-2026 World Outlook for Cancer Biomarkers
97% match

The 2021-2026 World Outlook for Cancer Biomarkers

£795.00 06 Nov 2026
2023-2028 US Cancer Screening Outlook - Market Study
97% match

2023-2028 US Cancer Screening Outlook - Market Study

£520.00 05 Nov 2026
Cancer Therapies in Asia 2016-2021 Outlook - Econometric Study
97% match

Cancer Therapies in Asia 2016-2021 Outlook - Econometric Study

£425.00 07 Nov 2026
The 2023-2028 Outlook for Cancer Testing-Screening in India
97% match

The 2023-2028 Outlook for Cancer Testing-Screening in India

£515.00 01 Oct 2026
Cancer Therapy Outlook 2016-2021 - North America & Caribbean
97% match

Cancer Therapy Outlook 2016-2021 - North America & Caribbean

£425.00 08 Nov 2026
The 2023-2028 Outlook for Cancer Testing-Screening in the United States
97% match

The 2023-2028 Outlook for Cancer Testing-Screening in the United States

£520.00 30 Sep 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in Japan
97% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in Japan

£495.00 25 Aug 2026
The 2016-2021 Outlook for Liver Cancer Drugs in Japan
96% match

The 2016-2021 Outlook for Liver Cancer Drugs in Japan

£595.00 27 Aug 2026